Manufacturer of Controlled Substances; Notice of Application; Cayman Chemical Company, 70188 [2012-28486]

Download as PDF 70188 Federal Register / Vol. 77, No. 226 / Friday, November 23, 2012 / Notices Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than January 22, 2013. company is granted registration as an importer of the basic classes of controlled substances listed. Dated: November 14, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. Dated: November 14, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2012–28485 Filed 11–21–12; 8:45 am] BILLING CODE 4410–09–P [FR Doc. 2012–28486 Filed 11–21–12; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration DEPARTMENT OF JUSTICE Manufacturer of Controlled Substances; Notice of Application; Cayman Chemical Company Drug Enforcement Administration Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on September 25, 2012, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108, made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule mstockstill on DSK4VPTVN1PROD with NOTICES JWH–250 (6250) .......................... SR–18 also known as RCS–8 (7008). JWH–019 (7019) .......................... JWH–081 (7081) .......................... SR–19 also known as RCS–4 (7104). JWH–122 (7122) .......................... AM–2201 (7201) ........................... JWH–203 (7203) .......................... 2C–T–2 (7385) ............................. JWH–398 (7398) .......................... Psilocybin (7437) .......................... Psilocyn (7438) ............................. 2C–D (7508) ................................. 2C–E (7509) ................................. 2C–H (7517) ................................. 2C–I (7518) .................................. 2C–C (7519) ................................. 2C–N (7521) ................................. 2C–P (7524) ................................. 2C–T–4 (7532) ............................. AM–694 (7694) ............................. Phenylacetone (8501) .................. 17:03 Nov 21, 2012 Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on September 14, 2012, Alltech Associates Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Jkt 229001 By Notice dated July 17, 2012, and published in the Federal Register on July 26, 2012, 77 FR 43863, Boehringer Ingelheim Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805–9372, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Amphetamine (1100) .................... Lisdexamfetamine (1205) ............. Methylphenidate (1724) ................ Methadone (9250) ........................ Methadone Intermediate (9254) ... Tapentadol (9780) ........................ Schedule II II II II II II Dated: November 14, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. Dated: November 14, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2012–28493 Filed 11–21–12; 8:45 am] [FR Doc. 2012–28496 Filed 11–21–12; 8:45 am] BILLING CODE 4410–09–P BILLING CODE 4410–09–P Schedule 2C-T-2 (2-(4-Ethylthio-2,5dimethoxyphenyl)ethanamine) (7385). 2C-1 (2-(4-lodo-2,5dimethoxyphenyl) Ethanamine) (7518). 2C-C (2-(4-Chloro-2,5dimethoxyphenyl) ethanamine (7519). I I I I I I I I I I I I I I I I I Manufacturer of Controlled Substances; Notice of Registration; Boehringer Ingelheim Chemicals, Inc. The company plans to manufacture high purity drug standards used for analytical applications only in clinical, toxicological, and forensic laboratories. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than January 22, 2013. Drug I I I Drug Enforcement Administration The company plans to manufacture the listed controlled substances in bulk for sale to its customers for formulation into finished pharmaceuticals. In reference to Methadone Intermediate (9254) the company plans to produce Methadone HCL active pharmaceutical ingredients (APIs) for sale to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Boehringer Ingelheim Chemicals, Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Boehringer Ingelheim Chemicals, Inc., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems; verification of the company’s compliance with state and local laws; and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. I I The company plans to manufacture the listed controlled substances for distribution to their research and forensics customers conducting drug testing and analysis. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement VerDate Mar<15>2010 Manufacturer of Controlled Substances; Notice of Application; Alltech Associates, Inc. DEPARTMENT OF JUSTICE PO 00000 Frm 00053 Fmt 4703 Sfmt 9990 I I I E:\FR\FM\23NON1.SGM 23NON1

Agencies

[Federal Register Volume 77, Number 226 (Friday, November 23, 2012)]
[Notices]
[Page 70188]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-28486]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; 
Cayman Chemical Company

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 25, 2012, Cayman 
Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108, 
made application to the Drug Enforcement Administration (DEA) to be 
registered as a bulk manufacturer of the following basic classes of 
controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
JWH-250 (6250).............................  I
SR-18 also known as RCS-8 (7008)...........  I
JWH-019 (7019).............................  I
JWH-081 (7081).............................  I
SR-19 also known as RCS-4 (7104)...........  I
JWH-122 (7122).............................  I
AM-2201 (7201).............................  I
JWH-203 (7203).............................  I
2C-T-2 (7385)..............................  I
JWH-398 (7398).............................  I
Psilocybin (7437)..........................  I
Psilocyn (7438)............................  I
2C-D (7508)................................  I
2C-E (7509)................................  I
2C-H (7517)................................  I
2C-I (7518)................................  I
2C-C (7519)................................  I
2C-N (7521)................................  I
2C-P (7524)................................  I
2C-T-4 (7532)..............................  I
AM-694 (7694)..............................  I
Phenylacetone (8501).......................  I
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
for distribution to their research and forensics customers conducting 
drug testing and analysis.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than January 22, 2013.

    Dated: November 14, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-28486 Filed 11-21-12; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.